Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
Kolmar patriarch wants shares gifted to son back amid sibling rivalry
In a dramatic and unprecedented legal move that has shaken South Korea’s corporate landscape, Kolmar Group founder and Chairman Yoon Dong-han ...
Hanwha acquires Ourhome for $622 million in push to revive food business
South Korea’s Hanwha Group has completed the acquisition of the country’s No. 2 food service and catering company Ourhome Ltd. for 869.5...
Samsung Biologics bags $514 mn CMO contract from US pharma
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...
Trump Jr. to visit Seoul next week to meet Korean business leaders
Donald Trump Jr., the eldest son of the US President Donald Trump, is set to visit Seoul next week and meet with Korean business leaders grappling w...
Hanwha gears up for 3rd-generation leadership with chairman’s stake gift
South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...
Samsung Biologics signs $1.4 bn CMO deal with European pharma
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...
Hanmi Pharm’s chair poised to win management feud with her son
Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Lotte replaces 21 CEOs, slashes executive jobs by 22% in drastic reshuffle
South Korea’s retail-to-chemical conglomerate Lotte Group on Thursday replaced 21 chief executives across its affiliates and slashed executive...
La Defense might have a say over Hanmi Pharm's family feud
La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca
Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...
LX Pantos founder’s son sells shares to LX International for $37 mn
The only son of LX Pantos Co.’s late founder has unloaded his additional shares in the company to South Korean logistics-to-trading conglomera...
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...
Lotte Group's heir apparent joins Japan holding firm's board
Shin Yoo-yeol, the heir apparent to Lotte Group, has been elected to the board of directors of its Japanese holding company, which serves as a link ...
Samsung Biologics eyes windfall gain amid US-China row
SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...
Hanmi to fire founder's wife, entering new round of family feud
South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...
HK inno.N to release K-CAB in MENA market
South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...
Hanmi’s planned merger with OCI scrapped as sons win family feud
Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...
Proxy advisor KCGS backs Hanmi founder's sons return to board
South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...
Lotte Group to give more authority to outside directors
Food-to-retail conglomerate Lotte will expand the authority of outside directors by separating the roles of chief executives and board chairs at its...
Samsung SDS gets CEIV Pharma certification
South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...
OCI-Hanmi merger faces tougher hurdles amid family feud
Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Lotte Group’s 3rd-generation son comes to the fore
Shin Yoo-yeol, the eldest son of Lotte Group Chairman Shin Dong-Bin, was promoted to lead the group’s new division to be launched within its h...
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
